Cambridge Journals Online

Christopher P. L.-H. Chen (). Regulatory Issues: An Academic Viewpoint From Asia (Ex-Japan). International Psychogeriatrics, 15 , pp 287-291
doi:10.1017/S1041610203009359

David S. Knopman (). Management of cognition and function: new results from the clinical trials programme of Aricept^® (donepezil HCl). The International Journal of Neuropsychopharmacology, 3 , pp S13-S20
doi:10.1017/S1461145700001905

Douglas Coyle and Michael F. Drummond (). ANALYZING DIFFERENCES IN THE COSTS OF TREATMENT ACROSS CENTERS WITHIN ECONOMIC EVALUATIONS. International Journal of Technology Assessment in Health Care, 17 , pp 155-163
doi:10.1017/S0266462301105015

D. Larry Sparks, Marwan N. Sabbagh, John C. S. Breitner and John C. Hunsaker III (). Is Cholesterol a Culprit in Alzheimer's Disease?. International Psychogeriatrics, 15 , pp 153-159
doi:10.1017/S1041610203009128

Steven H. Ferris (). General Measures of Cognition. International Psychogeriatrics, 15 , pp 215-217
doi:10.1017/S1041610203009220

Frederik Barkhof (). Guidelines for Brain Imaging in Vascular Dementia Clinical Trials. International Psychogeriatrics, 15 , pp 273-276
doi:10.1017/S1041610203009323

Bernard Ravina and Yuko Palesch (). The Phase II Futility Clinical Trial Design. Progress in Neurotherapeutics and Neuropsychopharmacology, 2 , pp 27-38
doi:10.1017/S1748232106000048

Douglas J. Minnich and Lyle L. Moldawer (). Anti-cytokine and anti-inflammatory therapies for the treatment of severe sepsis: progress and pitfalls. Proceedings of the Nutrition Society, 63 , pp 437-441
doi:10.1079/PNS2004378

Kenneth Rockwood (). The measuring, meaning and importance of activities of daily living (ADLs) as an outcome. International Psychogeriatrics, 19 , pp 467-482
doi:10.1017/S1041610207004966